Adenovirus-mediated gene therapy for bladder cancer in an orthotopic model using a dominant negative H-ras mutant

International Journal of Cancer

Volumn 92, Issue 5, 2001, Pages 712-717

  Watanabe, Takafumi ^b   Shinohara, Nobuo ^a,c   Sazawa, Ataru ^b   Takimoto, Masato ^b   Hashimoto, Akira ^b   Koyanagi, Tomohiko ^a   Kuzumaki, Noboru ^b  

^a HOKKAIDO UNIVERSITY   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

^c HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Adenoviral vector; Bladder cancer; Dominant negative H ras mutant; Gene therapy; Orthotopic model

Indexed keywords

BETA GALACTOSIDASE; N 116Y; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS VECTOR;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLADDER CANCER; BLADDER CARCINOGENESIS; CANCER INHIBITION; CELL INFILTRATION; CONTROLLED STUDY; CYTOMEGALOVIRUS; DRUG EFFICACY; FEMALE; GENE THERAPY; HUMAN; HUMAN CELL; MONONUCLEAR CELL; MOUSE; NONHUMAN; NUDE MOUSE; ONCOGENE H RAS; PRIORITY JOURNAL; PROMOTER REGION; VIRUS RECOMBINANT;

ADENOVIRIDAE; ANIMALS; GENE THERAPY; GENES, RAS; HUMANS; MICE; MUTATION; RNA, MESSENGER; TUMOR CELLS, CULTURED; URINARY BLADDER NEOPLASMS;

EID: 0035371856     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0215(20010601)92:5<712::AID-IJC1242>3.0.CO;2-Z     Document Type: Article

References (24)

1. New approaches in the treatment of metastatic transitional-cell cancer of the bladder
2. New approaches in the use of radiation therapy in the treatment of infiltrative transitional-cell cancer of the bladder
3. Urinary bladder transitional cell carcinogenesis is associated with down-regulation of NF1 tumor suppressor gene in vivo and in vitro
4. Ras oncogenes in human cancer: A review
5. The epidermal growth factor receptor and the prognosis of bladder cancer
6. Trans-dominant suppressor mutations of the H-ras oncogene
7. Suppression of various human tumor cell lines by a dominant negative H-ras mutant
8. Suppression of pancreatic cancer by the dominant negative ras mutant, N116Y
9. The significance of Ras guanine nucleotide exchange factor. Son of sevenless protein, in renal cell carcinoma cell lines
10. Methods for construction of adenovirus vectors
11. A review of adenoviruses in the etiology of acute hemorrhagic cystitis
12. Suppression of Erk activation and in vivo growth in esophageal cancer cells by the dominant negative ras mutant, N116Y
13. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
14. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays
15. Suppressive effects of dominant negative ras mutant N116Y on transformed phenotypes of human bladder cancer cells
16. Farnesyltransferase inhibition causes morphological reversion of ras-transformed cells by a complex mechanism that involves regulation of the actin cytoskeleton
17. Growth inhibition of human pancreatic cancer cell lines by anti-sense oligonucleotides specific to mutated K-ras genes
18. Intracellular expression of an antibody fragmentneutralizing p21 ras promotes tumor regression
19. An improved intravesical model using human bladder cancer cell lines to optimize gene and other therapies
20. Suppression of human bladder cancer growth by increased expression of C-CAM1 gene in an orthotopic model
21. Adenoviral-p53 gene transfer to orthotopic and peritoneal murine bladder cancer
22. Amplification of recombinant adenoviral transgene products occurs by inhibition of histone deacetylase
23. Gene therapy of cancer
24. C-erbB-2 gene amplification: A molecular marker in recurrent bladder tumors?